UBS Group’s SI-BONE Inc SIBN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.15M | Buy |
131,779
+83,528
| +173% | +$1.19M | ﹤0.01% | 5052 |
|
|
2026
Q1 | $609K | Sell |
48,251
-56,480
| -54% | -$884K | ﹤0.01% | 5938 |
|
|
2025
Q4 | $2.07M | Buy |
104,731
+89,105
| +570% | +$1.55M | ﹤0.01% | 4947 |
|
|
2025
Q3 | $230K | Sell |
15,626
-107,846
| -87% | -$1.76M | ﹤0.01% | 6592 |
|
|
2025
Q2 | $2.32M | Buy |
123,472
+70,682
| +134% | +$1.17M | ﹤0.01% | 4655 |
|
|
2025
Q1 | $741K | Sell |
52,790
-75,779
| -59% | -$1.22M | ﹤0.01% | 5541 |
|
|
2024
Q4 | $1.8M | Buy |
128,569
+109,094
| +560% | +$1.47M | ﹤0.01% | 4820 |
|
|
2024
Q3 | $272K | Sell |
19,475
-16,833
| -46% | -$253K | ﹤0.01% | 5646 |
|
|
2024
Q2 | $469K | Sell |
36,308
-32,183
| -47% | -$460K | ﹤0.01% | 5050 |
|
|
2024
Q1 | $1.12M | Buy |
68,491
+11,137
| +19% | +$210K | ﹤0.01% | 4507 |
|
|
2023
Q4 | $1.2M | Buy |
57,354
+25,522
| +80% | +$472K | ﹤0.01% | 4335 |
|
|
2023
Q3 | $676K | Buy |
31,832
+769
| +2% | +$17.8K | ﹤0.01% | 4414 |
|
|
2023
Q2 | $838K | Buy |
31,063
+28,105
| +950% | +$685K | ﹤0.01% | 4392 |
|
|
2023
Q1 | $58.2K | Sell |
2,958
-9,049
| -75% | -$161K | ﹤0.01% | 6328 |
|
|
2022
Q4 | $163K | Buy |
12,007
+7,157
| +148% | +$104K | ﹤0.01% | 5634 |
|
|
2022
Q3 | $84K | Buy |
4,850
+1,105
| +30% | +$17.7K | ﹤0.01% | 5863 |
|
|
2022
Q2 | $49K | Sell |
3,745
-422
| -10% | -$7.03K | ﹤0.01% | 5934 |
|
|
2022
Q1 | $95K | Sell |
4,167
-6,883
| -62% | -$143K | ﹤0.01% | 5971 |
|
|
2021
Q4 | $245K | Buy |
11,050
+10,844
| +5,264% | +$233K | ﹤0.01% | 5516 |
|
|
2021
Q3 | $4K | Buy |
206
+155
| +304% | +$3.92K | ﹤0.01% | 8676 |
|
|
2021
Q2 | $2K | Sell |
51
-7,977
| -99% | -$258K | ﹤0.01% | 8976 |
|
|
2021
Q1 | $255K | Buy |
8,028
+2,269
| +39% | +$69.8K | ﹤0.01% | 5312 |
|
|
2020
Q4 | $172K | Buy |
5,759
+5,188
| +909% | +$126K | ﹤0.01% | 5329 |
|
|
2020
Q3 | $13K | Sell |
571
-8,995
| -94% | -$179K | ﹤0.01% | 6646 |
|
|
2020
Q2 | $152K | Sell |
9,566
-1,718
| -15% | -$27.1K | ﹤0.01% | 4997 |
|
|
2020
Q1 | $135K | Sell |
11,284
-8,711
| -44% | -$160K | ﹤0.01% | 5033 |
|
|
2019
Q4 | $430K | Buy |
19,995
+8,292
| +71% | +$149K | ﹤0.01% | 4969 |
|
|
2019
Q3 | $206K | Buy |
11,703
+6,965
| +147% | +$133K | ﹤0.01% | 5226 |
|
|
2019
Q2 | $96K | Buy |
4,738
+4,614
| +3,721% | +$79.2K | ﹤0.01% | 5403 |
|
|
2019
Q1 | $2K | Sell |
124
-3,891
| -97% | -$75.3K | ﹤0.01% | 7467 |
|
|
2018
Q4 | $84K | Buy |
+4,015
| New | +$76K | ﹤0.01% | 5680 |
|
Other funds holding SIBN
FLAM
CCM
GIM
GGHC
PCMI
UBS Group's SIBN Position: Q2 2026 in Review
UBS Group increased its SI-BONE Inc (SIBN) stake by 173% in Q2 2026, buying an estimated $1.19M and bringing the position to 131,779 shares worth $2.15M. The position accounts for ﹤0.01% of the portfolio, ranked #5052.
UBS Group first reported a position in SIBN in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.32M in Q2 2025. 167 funds tracked by Wall St. Rank hold SIBN as of Q2 2026.
- UBS Group held 131,779 shares of SI-BONE Inc worth $2.15M as of Q2 2026.
- UBS Group bought 83,528 SI-BONE Inc shares in Q2 2026, an estimated $1.19M.
- SI-BONE Inc made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #5052 holding.
- UBS Group first reported a position in SI-BONE Inc in Q4 2018 and has held it in 31 quarters since.
- UBS Group's SI-BONE Inc position peaked at $2.32M in Q2 2025.
- 167 funds tracked by Wall St. Rank held SI-BONE Inc as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.